
Hold, $545 target: the price pays for Azure's growth but not the FY28 margin step-down
We initiate at Hold with a $545 target, a +3.5% total return. Microsoft sells cloud infrastructure (Azure, 31% of FY26 revenue), Microsoft 365 subscriptions, Windows, Xbox and search. The market is right on Azure growth and light on its cost: our weighted value is $503, 5.2% below the price.
- Azure stays above 40% in FY27, so revenue lands within 1% of consensus. FY27E revenue is $395.0bn (+19.0%) against $399.0bn; backlog (RPO) is $677bn, +73%.
- Depreciation cuts FY28E operating margin to 43.7%, against about 47% implied by consensus. D&A rises from $38.5bn to $82.0bn; FY28E EPS is $21.90 against $24.14, worth $54 a share.
- The price already pays for the AI build. At 24.7x forward EPS against our 22.55x target multiple, the price implies Azure growth 1.2pts higher every year.
What the market is missing. Revenue is close ($470bn against $477bn in FY28E); the gap is cost. About $350bn of FY26-FY27 capex, mostly short-lived, hits the income statement from FY28.
Catalysts. OpenAI round close (Dec 2026); FQ2 results (late Jan 2027, Azure guided +49-50%); FQ4 call with the FY28 outlook (late Jul 2027).
Valuation and target. DCF (WACC 8.9%, terminal growth 3.0%) gives $489; P/E at 22.55x plus the OpenAI stake gives $487. Bear $272 (20%), base $489 (50%), bull $681 (30%) weight to $503; upside to downside is 0.6x.
Risks. A 1pt lower discount rate lifts weighted value to $619 (Buy), 1pt higher cuts it to $422 (Sell); conviction is low. Against us: 43 of 49 analysts rate it Buy.
| Year to 30 Jun | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue ($bn) | 281.7 | 331.8 | 395.0 | 469.8 | 547.2 |
| Growth y/y | 14.9% | 17.8% | 19.0% | 18.9% | 16.5% |
| EBITDA ($bn) | 157.9 | 193.8 | 240.9 | 287.5 | 336.5 |
| Margin | 56.1% | 58.4% | 61.0% | 61.2% | 61.5% |
| Net income ($bn) | 101.8 | 133.7 | 145.6 | 162.2 | 180.6 |
| EPS, diluted ($) | 13.64 | 17.95 | 19.55 | 21.90 | 24.67 |
| Growth y/y | 15.6% | 31.6% | 8.9% | 12.0% | 12.7% |
| Free cash flow ($bn) | 71.6 | 67.0 | 41.1 | 65.5 | 105.5 |
| At $530.61 | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| P/E | 38.9x | 29.6x | 27.1x | 24.2x | 21.5x |
| EV/EBITDA | 25.3x | 20.6x | 16.6x | 13.9x | 11.9x |
| P/B | 11.5x | 8.9x | 7.1x | 5.9x | 5.1x |
| FCF yield | 1.8% | 1.7% | 1.0% | 1.7% | 2.7% |
| Dividend yield | 0.63% | 0.69% | 0.73% | 0.78% | 0.85% |
| ROE | 33.3% | 34.0% | 29.1% | 26.5% | 25.3% |
| Net debt / EBITDA | −0.33x | −0.19x | −0.13x | −0.07x | −0.03x |
| P/E at our $545 target | 40.0x | 30.4x | 27.9x | 24.9x | 22.1x |
Source: Company filings (A); Penmark Research model (E). FY25A-FY26A EPS is GAAP incl. OpenAI; FY27E onward excludes OpenAI gains and losses. FCF is cash from operations less cash capex. Net debt excludes finance leases; ROE on average equity. Multiples at the 6 Nov 2026 price, except the last row.
Base value is $489 and weighted value $503: $150 of upside against $259 of downside leaves a Hold
Source: Yahoo Finance closes (history); Penmark Research model (scenarios)
Azure +47% FY27, +40% FY28; capex 44% of revenue in FY28; OpenAI $1.25tn. FY28E EPS $24.47.
Azure +44.5% FY27, +35% FY28; capex 52% then 47.5%; OpenAI $852bn. FY28E EPS $21.90.
OpenAI trims commitments; Azure +24% FY28; costs fixed; OpenAI $500bn. FY28E EPS $18.21.
| Income, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue | 281.7 | 331.8 | 395.0 | 469.8 | 547.2 |
| Gross profit | 193.9 | 225.5 | 259.3 | 294.8 | 332.7 |
| EBITDA | 157.9 | 193.8 | 240.9 | 287.5 | 336.5 |
| EBIT | 128.5 | 155.2 | 183.6 | 205.5 | 229.7 |
| Fin. and other | −4.9 | 10.7 | −1.6 | −2.8 | −4.0 |
| Tax | −21.8 | −32.2 | −36.4 | −40.5 | −45.1 |
| Net income | 101.8 | 133.7 | 145.6 | 162.2 | 180.6 |
| Tax rate | 17.6% | 19.4% | 20.0% | 20.0% | 20.0% |
| Cash flow, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Net income | 101.8 | 133.7 | 145.6 | 162.2 | 180.6 |
| D&A | 29.4 | 38.5 | 57.3 | 82.0 | 106.8 |
| SBC and other | 10.3 | 15.5 | 13.4 | 16.0 | 18.6 |
| Working capital | −5.3 | −4.9 | 5.2 | 6.1 | 6.3 |
| Op. cash flow | 136.2 | 182.9 | 221.5 | 266.3 | 312.3 |
| Cash capex | −64.6 | −115.9 | −180.4 | −200.8 | −206.8 |
| Free cash flow | 71.6 | 67.0 | 41.1 | 65.5 | 105.5 |
| Payouts | −42.5 | −48.7 | −42.1 | −71.1 | −107.2 |
| Balance, $bn | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Cash, invest. | 94.6 | 76.8 | 87.0 | 75.3 | 66.4 |
| Receivables | 69.9 | 80.9 | 96.3 | 114.5 | 133.4 |
| PP&E, net | 205.0 | 313.1 | 464.1 | 608.2 | 733.8 |
| Total assets | 619.0 | 758.4 | 941.1 | 1,100.0 | 1,244.6 |
| Debt | 43.2 | 40.3 | 56.1 | 56.1 | 56.1 |
| Unearned rev. | 67.3 | 75.7 | 90.1 | 107.2 | 124.8 |
| Net debt | −51.4 | −36.5 | −30.9 | −19.2 | −10.4 |
| Equity | 343.5 | 442.4 | 559.3 | 666.3 | 758.3 |
| Per share, KPIs | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Dil. shares (m) | 7,465 | 7,453 | 7,446 | 7,405 | 7,318 |
| EPS ($) | 13.64 | 17.95 | 19.55 | 21.90 | 24.67 |
| DPS ($) | 3.32 | 3.64 | 3.85 | 4.16 | 4.49 |
| FCF/share ($) | 9.59 | 8.99 | 5.52 | 8.84 | 14.42 |
| BVPS ($) | 46.01 | 59.36 | 75.11 | 89.99 | 103.63 |
| Azure ($bn) | 72.6 | 101.9 | 147.3 | 198.9 | 252.5 |
| M365 ($bn) | 84.6 | 100.3 | 118.4 | 137.3 | 156.5 |
| Azure % of rev. | 25.8% | 30.7% | 37.3% | 42.3% | 46.2% |
Source: Company filings (A); Penmark Research model (E). Exhibit 3 rolls scenario values to 6 Nov 2027 at the cost of equity less dividend yield. Years end 30 June. FY25A-FY26A net income is GAAP incl. OpenAI; FY27E on excludes it. Cash capex and net debt exclude finance-leased assets. Bold = totals and thesis lines; italic = ratios.
Returns stay above 24% ROE, but margins and FCF are where we differ from consensus: FY28E EPS is 9.3% lower
| Growth, margins (%) | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Growth y/y | |||||
| Sales | 14.9% | 17.8% | 19.0% | 18.9% | 16.5% |
| EBITDA | – | 22.7% | 24.3% | 19.3% | 17.0% |
| EBIT | 17.4% | 20.8% | 18.3% | 11.9% | 11.8% |
| EPS | 15.6% | 31.6% | 8.9% | 12.0% | 12.7% |
| DPS | 10.7% | 9.6% | 5.8% | 8.0% | 8.0% |
| Margins and intensity | |||||
| Gross margin | 68.8% | 67.9% | 65.7% | 62.8% | 60.8% |
| EBITDA margin | 56.1% | 58.4% | 61.0% | 61.2% | 61.5% |
| EBIT margin | 45.6% | 46.8% | 46.5% | 43.7% | 42.0% |
| FCF margin | 25.4% | 20.2% | 10.4% | 13.9% | 19.3% |
| D&A / sales | 10.4% | 11.6% | 14.5% | 17.5% | 19.5% |
| Capex / sales | 22.9% | 34.9% | 45.7% | 42.7% | 37.8% |
| Ratios and valuation | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Returns and leverage | |||||
| ROE | 33.3% | 34.0% | 29.1% | 26.5% | 25.3% |
| ROA | 18.0% | 19.4% | 17.1% | 15.9% | 15.4% |
| ROCE | 33.2% | 32.2% | 29.8% | 28.4% | 28.2% |
| Net debt / equity | −15.0% | −8.3% | −5.5% | −2.9% | −1.4% |
| Net debt / EBITDA | −0.33x | −0.19x | −0.13x | −0.07x | −0.03x |
| Valuation at $530.61 | |||||
| P/E | 38.9x | 29.6x | 27.1x | 24.2x | 21.5x |
| EV/EBITDA | 25.3x | 20.6x | 16.6x | 13.9x | 11.9x |
| P/B | 11.5x | 8.9x | 7.1x | 5.9x | 5.1x |
| FCF yield | 1.8% | 1.7% | 1.0% | 1.7% | 2.7% |
| Dividend yield | 0.63% | 0.69% | 0.73% | 0.78% | 0.85% |
| P/E at our $545 target | 40.0x | 30.4x | 27.9x | 24.9x | 22.1x |
Source: Company filings (A); Penmark Research model (E). ROE and ROA on average balances; ROCE is EBIT over equity plus debt; net debt excludes finance leases. FY25A-FY26A EPS growth is GAAP incl. OpenAI. Multiples at the 6 Nov 2026 share price, except the last row.
| $bn / $ per share | FY27E | FY28E |
|---|---|---|
| Revenue ($bn) | ||
| Penmark estimate | 394.97 | 469.82 |
| Consensus | 398.96 | 477.21 |
| Prior-year period | 331.84 | 394.97 |
| Diff. vs consensus | −1.0% | −1.5% |
| Growth y/y (Penmark) | +19.0% | +18.9% |
| EPS excl. OpenAI ($) | ||
| Penmark estimate | 19.55 | 21.90 |
| Consensus | 20.02 | 24.14 |
| Prior-year period | 17.28 | 19.55 |
| Diff. vs consensus | −2.3% | −9.3% |
| Growth y/y (Penmark) | +13.1% | +12.0% |
Source: Company filings; consensus per 247 Wall St (EPS, 5 Nov 2026) and Chartmill (revenue, Oct 2026); Penmark Research model. Prior-year EPS is the sum of reported quarterly EPS excluding OpenAI for FY26A.
Source: Company filings (A), Penmark Research model (E), 247 Wall St consensus ($20.02 FY27E, $24.14 FY28E). FY24A-FY26A are GAAP incl. OpenAI; FY27E onward excludes it. EPS by year in Exhibit 10.
Four dated events decide the call, and at 27.7x trailing earnings the stock is one deviation below its own average
| Latest, 6 Nov 2026 | MSFT | Peers | Diff. |
|---|---|---|---|
| Valuation | |||
| P/E, next 12m | 24.7x | 19.3x | +28% |
| P/E, platform peers | 24.7x | 22.6x | +10% |
| Returns and growth | |||
| Operating margin | 49.8% | 25.8% | +24.0pp |
| ROIC | 25.7% | 16.0% | +9.7pp |
Source: Motley Fool, Zacks (P/E, 2-6 Nov 2026); Company filings, key metrics (latest quarter); Penmark Research. Eight peers; platform peers are Alphabet, Amazon, Meta, Apple. Difference in % for multiples, pp for ratios.
Source: Yahoo Finance closes; reported diluted EPS (GAAP, incl. OpenAI), Dec 2021 to 6 Nov 2026; Penmark Research. Dashed line = mean 32.5x; shading = ±1 and ±2 standard deviations.
- Dec 2026OpenAI round closes; our $852bn basis is 32% below the $1.25tn first close ($13 a share, base re-run).
- Late Jan 2027FQ2 results: Azure guided +49-50%; we model FY27E +44.5%. Capex guide over $50bn.
- Jan-May 2027Texas session on data-centre moratoria: +$3.50 a share in the bull case if supply is capped; permit freezes cost $2.50 in the bear case.
- Late Jul 2027FQ4 call and FY28 outlook: we expect 43.7% operating margin, consensus about 47%.
Source: Company calendar; Penmark Research model.
- Depreciation catch-up. D&A reaches $82bn in FY28E on $350bn of short-lived capex. Likelihood High; −$17.80/share (P/E bridge).
- OpenAI trims commitments. 11% of FQ1 revenue; $7.2bn receivable. Likelihood Low; −$3.50/share.
- Permit freezes delay capacity. Third-party GPU capacity slips beyond H2 FY27. Likelihood Medium; −$2.50/share.
- Azure stays near 40% in FY28 (runs against Hold). Fleet efficiency lifts capacity. Likelihood Medium; +$7.50/share.
Source: Penmark Research model; next-twelve-month P/E bridge, which understates long-run effects.
Source: Motley Fool, Zacks (P/E, 2-6 Nov 2026); company filings, key metrics (ROIC); Penmark Research. Seven uncovered peers; Oracle has no ROIC.
The stock trades on operating margin (0.64 correlation), and our FY28 margin is 3 points below the Street
Source: Company filings; Yahoo Finance quarter-end closes; Penmark Research. Latest quarter (FQ1 FY27): operating margin 49.8%, price $513. Eight quarters is a small sample.
Source: Form 8-K, 2 Sep 2026 (restated FY27 structure); Form 10-Q FQ1 FY27
Source: Company filings and earnings calls, FQ2 FY25 to FQ1 FY27
Source: Chartmill, TIKR (consensus, Oct 2026, before the FQ1 print); Penmark Research model. Prior year = last reported or forecast fiscal year.
Source: Earnings calls and Form 10-Q, FQ2 FY25 to FQ1 FY27 (fiscal quarters)
| Rating move | Test | Value / share | Return to value | Rating (return-to-value rule) |
|---|---|---|---|---|
| Upgrade | Discount rate 1 point lower | $618.50 | +16.6% | Buy |
| Upgrade | Bull case (Azure +40% in FY28) | $680.75 | +28.3% | Buy |
| Hold | Base case alone | $489.40 | −7.8% | Hold |
| Downgrade | Beta at high end (1.10) | $463.49 | −12.7% | Sell |
| Downgrade | Discount rate 1 point higher | $422.12 | −20.5% | Sell |
Source: Penmark Research model (robustness tests). Discount-rate and beta rows are probability-weighted values against the $530.61 price on 6 Nov 2026 (base $503.28); base and bull rows are single-case DCF values. For the base case alone, a 1pt move in discount rate gives $601 and $410 (Exhibit 42).
The call rests on one debate worth $54 a share: whether depreciation pulls FY28 margin toward 44%
| Debate | Market view | Penmark view | Evidence | What changes our view | Resolves |
|---|---|---|---|---|---|
| 1. FY28 margin and the D&A catch-up | FY28 EPS $24.14, operating margin near 47% | FY28 EPS $21.90, margin 43.7% | D&A $12.1bn in FQ1, +41% y/y; FY26-27 capex about $350bn, 72% short-lived | FY28 outlook implying margin above 46% | Late Jul 2027 (FQ4 call) |
| 2. Azure durability beyond FY27 | FY29 revenue $581bn | FY29 revenue $547bn | Azure +48% in FQ1; guide +49-50%; RPO $677bn, +73%; capacity-bound | Azure above 40% in FY28 with capacity added | Late Jan 2027 (FQ2) |
| 3. Value of the OpenAI stake | $1.25tn, Nov 2026 round | $852bn, Mar 2026 round | 24% stake worth $27.46 a share at $852bn; OpenAI is 11% of FQ1 revenue | Round closing at or above $1.25tn | Dec 2026 |
| 4. Required return on the AI build | Equity risk premium 4.93%, the premium that reconciles the market-view cash flows of debates 1-3 to the price | Equity risk premium 4.23% on our base-case cash flows | On our base-case cash flows the price implies WACC of 8.46% against our 8.88% | Capex update showing returns above cost of capital | Late Jan 2027 (FQ2) |
| 5. Copilot monetisation | Seat plus consumption pricing lifts Microsoft 365 cloud | Microsoft 365 cloud +18% FY27E, +16% FY28E | FQ2 guide about 19% vs 17% in FQ1; credit-consuming Copilot customers +75% q/q; paid seats +5%, the series low | Microsoft 365 cloud above 19% growth | FQ2-FQ4 FY27 |
Source: Company filings and calls; Penmark Research model (Market Check, debate re-runs, base case).
Source: Penmark Research model (debate re-runs, applied in sequence, base case); $ per share
Source: Company calendar; Penmark Research
Azure and Microsoft 365 cloud are 61% of revenue and all of the FY27E growth, at a 47% operating margin
Source: Company filings, FY26A (year to 30 Jun 2026), $bn; Other is Industry solutions, Frontier and support, Windows OEM and devices
Source: Company filings (FY26A); Penmark Research model (FY27E); highlighted boxes are the drivers we forecast
Source: Earnings calls and Form 10-Q, FQ1 FY27 (quarter to 30 Sep 2026)
The stock trades on the multiple, not on earnings: two drivers, FY28 margin and Azure growth, explain it
| Driver | What moves the stock | Tests confirmed | Market vs our value | Debate | Next number |
|---|---|---|---|---|---|
| FY28 operating margin | Margin and price move together (0.64); the multiple fell 22% in a year while EPS rose 36% | Return decomposition; quarterly margin correlation | $543 at consensus margin vs $489 ours: $54, 11% | 1 | Late Jul 2027: FY28 outlook; we expect 43.7%, consensus about 47% |
| Azure growth | Jul 2026 +15.5% on Azure +43%; Azure revenue is up 91% in seven quarters | Event-day reaction; sensitivity | $583 at consensus FY29 revenue vs $543: $40, 7% | 2 | 27 Jan 2027: FQ2 Azure +49-50% guided; we model FY27E +44.5% |
Source: Yahoo Finance; company filings; Penmark Research model (Market Check, debate re-runs, applied in sequence).
| Results | EPS beat | Next day | vs S&P |
|---|---|---|---|
| Oct 24 | +6.1% | −6.1% | −4.2pp |
| Jan 25 | +3.5% | −6.2% | −6.7pp |
| Apr 25 | +7.4% | +7.6% | +7.0pp |
| Jul 25 | +8.1% | +3.9% | +4.3pp |
| Oct 25 | +12.7% | −2.9% | −1.9pp |
| Jan 26 | +5.7% | −10.0% | −9.9pp |
| Apr 26 | +4.8% | −3.9% | −5.0pp |
| Jul 26 | +11.8% | +15.5% | +13.8pp |
| Oct 26 | +3.6% | −0.2% | +0.1pp |
Source: Yahoo Finance closes, reported against estimated EPS, Oct 2024 to Oct 2026; correlation of beat and move 0.54, driven by Jul 2026 (+15.5%).
Source: Yahoo Finance closes; trailing P/E on reported diluted EPS (incl. OpenAI), 35.4x to 27.7x; multiplicative split, $ per share
| Weekly returns, 158 weeks | R² |
|---|---|
| S&P 500 alone | 0.34 |
| Technology sector ETF (XLK) alone | 0.34 |
| S&P 500 and XLK together | 0.36 |
Source: Yahoo Finance weekly closes, Nov 2023 to 6 Nov 2026; Penmark Research regression.
| Candidate tested | Result | Verdict |
|---|---|---|
| Size of the EPS beat | Beat nine times; fell after six; Jan 2026 fell 10.0% on a 5.7% beat | Dropped |
| Market and sector direction | R² 0.34 to 0.36; leaves two thirds unexplained | Context, not a driver |
Source: Yahoo Finance; Penmark Research. Limits: nine results and three years of weekly data; earnings-call question counts were not tested.
We forecast 19% revenue growth in FY27E, in line with guidance; depreciation then cuts margin by 2.7 points in FY28E
Source: Synergy Research Group via CRN, Q3 2026 (share of $168bn, % of spend); share is for a broader scope than company-reported Azure revenue
Source: Company filings (A); Penmark Research model (E), $bn; capex includes finance-leased assets
Source: Company filings (A); Penmark Research model (E); consensus-implied margin of 47.0% from EPS $24.14 on revenue $477bn (247 Wall St, Chartmill, 5 Nov 2026). Margins: 45.6%, 46.8%, 46.5%, 43.7%, 42.0%, 41.1%.
| Line | Consensus | Penmark | Gap |
|---|---|---|---|
| Revenue FY27E | $398.96bn | $394.97bn | −1.0% |
| Revenue FY28E | $477.21bn | $469.82bn | −1.5% |
| Revenue FY29E | $581.38bn | $547.17bn | −5.9% |
| EPS FY27E | $20.02 | $19.55 | −2.3% |
| EPS FY28E | $24.14 | $21.90 | −9.3% |
Source: Chartmill, 247 Wall St, TIKR (consensus, Oct-Nov 2026; revenue before the FQ1 print); Penmark Research model.
| Management guidance | Period | Guided | Penmark model | Inside? |
|---|---|---|---|---|
| Revenue | FQ2 FY27 | $96.0-97.1bn | $96.7bn | Yes |
| Revenue growth | FY27 | Double digits | +19.0% | Yes |
| Operating margin, down under 1 point from 46.8% | FY27 | 45.8-46.8% | 46.5% | Yes |
| Operating expense growth | FY27 | 4-9% | 7.9% | Yes |
| Windows OEM and devices | FY27 | −16% to −19% | −18% | Yes |
| Free cash flow, reported basis | FY27 | Positive | $41.1bn | Yes |
Source: Q4 FY26 call (29 Jul 2026) and Q1 FY27 call (28 Oct 2026); Penmark Research model (Guidance).
Value of $503 a share is 5% below the price: DCF and P/E agree at $489 and $487, and the weighted value sets a $545 target
Source: Penmark Research model (DCF value per share at 6 Nov 2026; ±1pt rows hold terminal growth at 3.0%); Street targets 247 Wall St, tickernerd, Oct-Nov 2026. Our 12-month target of $545.07 is the weighted value ($503.28) rolled forward.
Source: Penmark Research model, DCF full re-runs at 6 Nov 2026; probabilities are analyst assumptions fixed before valuation
| Step | Value / share |
|---|---|
| DCF, base case (primary) | $489.40 |
| P/E cross-check: 22.55x on $20.38 EPS plus stake | $487.08 |
| Probability-weighted value (20/50/30) | $503.28 |
| Return to value against $530.61 | −5.2% |
| 12-month target (value × (1 + 9.0% cost of equity − 0.7% yield)) | $545.07 |
| Total return to target, with dividend | +3.5% |
Source: Penmark Research model (Valuation, Market Check). Hold on the model rule (return to value inside ±10%); the +3.5% total return to target is also inside ±10%.
Source: Penmark Research model (Scenarios), base-case DCF value per share; cash flows held. Weighted-value sensitivity is $619 / $422 (Exhibit 22).
| What the $530.61 price implies | Our model | Price implies |
|---|---|---|
| Terminal growth | 3.00% | 4.35% |
| Discount rate (WACC) | 8.88% | 8.46% |
| Azure growth, every forecast year | Base path | +1.2pts |
| P/E on next-12-month EPS | 22.55x | 24.69x |
Source: Penmark Research model (Market Check, reverse DCF; each solve plugs back to $530.61).
The next nine months bring five dated tests; the FY28 outlook in July 2027 is the one that can end the Hold
Source: Company calendar; Penmark Research model (Thesis catalysts)
| Case | Catalyst | Timing | $ / share | Probability | In consensus? |
|---|---|---|---|---|---|
| Bull | Azure above 45% in FY27, near 40% in FY28 | FQ2, FQ3 prints | +7.50 | 35% | Partly |
| Bull | Copilot and usage billing lift Microsoft 365 cloud | FQ2-FQ4 | +5.00 | 40% | Partly |
| Bull | In-house models cut inference cost | Through FY27 | +7.00 | 30% | Partly |
| Bull | State moratoria slow capex | Jan-May 2027 | +3.50 | 30% | Not priced |
| Bear | Depreciation catch-up: D&A of about $82bn in FY28 | Late Jul 2027 | −17.80 | 70% | Not priced |
| Bear | OpenAI trims or delays commitments | FY27 H2 | −3.50 | 20% | Not priced |
| Bear | Permit freezes cap H2 FY27 Azure | FQ3 print | −2.50 | 35% | Partly |
| Bear | Windows OEM falls on memory-driven PC prices | FQ2-FQ3 | −1.80 | 30% | Partly |
Source: Penmark Research model (Thesis catalysts); impacts use the next-twelve-month P/E bridge and understate long-run effects. Not every catalyst is shown.
| Risk to the Hold | Direction | Mechanism | Likelihood |
|---|---|---|---|
| Depreciation hits FY28 margin | Downside | $350bn of short-lived capex; EPS −$2.00 in FY28 | High |
| OpenAI concentration | Downside | 11% of FQ1 revenue; $7.2bn receivable | Low |
| Fleet efficiency frees capacity | Upside | Azure near 40% in FY28; value $681 in the bull case | Medium |
| Lower discount rate | Upside | One point lower gives $618.50, a Buy | Market-driven |
Source: Penmark Research model (Thesis, Market Check). Regulatory, legal and key-person risks are not separately valued in the model.
Ownership is index-heavy and the Street is 88% Buy; short interest is falling
Source: SEC Form 13F filings, period 30 Jun 2026; reported holders cover 73.7% of shares outstanding; value in $bn
Source: FINRA equity short interest, 30 Jun to 15 Oct 2026; y-axis in m shares; days to cover 3.2 at 15 Oct
Source: 247 Wall St, 5 Nov 2026 (mean); tickernerd, Oct 2026 (high, low); Penmark Research
Source: MarketBeat summary, Oct 2026; 247 Wall St, 5 Nov 2026
| Insider and date | Shares | Value | Plan |
|---|---|---|---|
| CFO A. Hood, 13 Oct 2026 | 2,927 | $1.60m | 10b5-1 |
| CFO A. Hood, 13 Oct 2026 | 991 | $0.54m | 10b5-1 |
| EVP A. Coleman, 15 Oct 2026 | 32 | $0.02m | Tax |
Source: SEC Form 4 filings, Oct 2026. After the sales Ms Hood holds 555,396 shares.
| Trading data | Value |
|---|---|
| Average daily traded value, 3 months | $11.8bn |
| Market value, 6 Nov 2026 | $3,951bn |
| 52-week closing range | $352.83-$555.80 |
| Days to cover, 15 Oct 2026 | 3.2 |
| Next results | 27 Jan 2027 |
Source: Yahoo Finance (traded value, closing range, dates); FINRA; Penmark Research.
Capital allocation has shifted from returns to the build: capex is 81% of operating cash flow in FY27E, up from 27% in FY22A
Source: Company filings FY22A-FY26A (cash flow statement); Penmark Research model FY27E-FY29E. Cash from operations: $182.9bn FY26A, $221.5bn FY27E
| $bn | FY25A | FY26A | FY27E | FY28E |
|---|---|---|---|---|
| Cash from operations | 136.2 | 182.9 | 221.5 | 266.3 |
| Cash capex | 64.6 | 115.9 | 180.4 | 200.8 |
| Free cash flow, reported | 71.6 | 67.0 | 41.1 | 65.5 |
| Dividends | 24.1 | 26.4 | 28.7 | 31.0 |
| Buybacks | 18.4 | 22.3 | 13.4 | 40.2 |
| Diluted shares (m) | 7,465 | 7,453 | 7,446 | 7,405 |
Source: Company filings (A); Penmark Research model (E). Buybacks offset issuance in FY27E. From FY28E the model sets buybacks above FCF after dividends ($40.2bn against $34.5bn in FY28E; about $74bn against $62bn in FY29E) and funds the gap from cash and investments.
| FQ1 FY27 (quarter to 30 Sep 2026) | Guided | Reported | Outcome |
|---|---|---|---|
| Revenue | $89.85-90.95bn | $92.28bn | Above |
| Azure growth, constant currency | 44-45% | 48% | Above |
| Cost of revenue | $29.6-29.8bn | $29.72bn | Inside |
| Operating expenses | $16.8-16.9bn | $16.64bn | Below |
Source: Company outlook slides (8-K, 2 Sep 2026) and FQ1 FY27 release; Penmark Research model (Guidance). EPS has beaten estimates in nine of nine quarters (Exhibit 30).
| Item | Fact |
|---|---|
| CEO and chair | Satya Nadella; FY26 reported pay $90.6m, down 6% on FY25 ($96.5m); stock awards $77.6m |
| Board | 2025 proxy: 11 of 12 nominees independent; Sandra Peterson lead independent director |
| OpenAI | 24% stake valued at $27.46 a share; OpenAI was $10.0bn (11%) of FQ1 revenue and owes $7.2bn |
Source: Microsoft 2026 proxy statement (summary); 2025 proxy statement; SEC Form 4 filings; company 10-Q FQ1 FY27; Penmark Research model.
The model: revenue compounds at 18% a year to FY29E while operating margin falls 4.8 points from FY26A
| Years to 30 June | FY25A | FY26A | FY27E | FY28E | FY29E |
|---|---|---|---|---|---|
| Revenue ($bn) | 281.7 | 331.8 | 395.0 | 469.8 | 547.2 |
| Growth | – | 17.8% | 19.0% | 18.9% | 16.5% |
| EBITDA ($bn) | 157.9 | 193.8 | 240.9 | 287.5 | 336.5 |
| EBITDA margin | 56.1% | 58.4% | 61.0% | 61.2% | 61.5% |
| D&A ($bn) | 29.4 | 38.5 | 57.3 | 82.0 | 106.8 |
| Operating income ($bn) | 128.5 | 155.2 | 183.6 | 205.5 | 229.7 |
| Operating margin | 45.6% | 46.8% | 46.5% | 43.7% | 42.0% |
| Net income ($bn) | 101.8 | 133.7 | 145.6 | 162.2 | 180.6 |
| Diluted EPS ($) | $13.64 | $17.95 | $19.55 | $21.90 | $24.67 |
| Dividend per share ($) | – | – | $3.85 | $4.16 | $4.49 |
| Cash from operations ($bn) | 136.2 | 182.9 | 221.5 | 266.3 | 312.3 |
| Capex incl. finance leases ($bn) | – | 145.3 | 205.0 | 223.2 | 229.8 |
| Free cash flow, reported ($bn) | 71.6 | 67.0 | 41.1 | 65.5 | 105.5 |
| Cash and short-term investments ($bn) | – | 76.8 | 87.0 | 75.3 | 66.4 |
Source: Company filings (A); Penmark Research model (E, shaded). FY26A EPS includes OpenAI gains; forecasts exclude OpenAI results. Dash = not reported on a comparable basis.
| Fiscal quarters | FQ2 25 | FQ3 25 | FQ4 25 | FQ1 26 | FQ2 26 | FQ3 26 | FQ4 26 | FQ1 27 |
|---|---|---|---|---|---|---|---|---|
| Revenue ($bn) | 69.6 | 70.1 | 76.4 | 77.7 | 81.3 | 82.9 | 90.0 | 92.3 |
| Growth y/y | – | – | – | – | 16.7% | 18.3% | 17.7% | 18.8% |
| Azure ($bn) | 17.3 | 18.5 | 20.7 | 22.4 | 24.1 | 26.0 | 29.4 | 33.2 |
| Operating income ($bn) | 31.7 | 32.0 | 34.3 | 38.0 | 38.3 | 38.4 | 40.6 | 45.9 |
| Operating margin | 45.5% | 45.7% | 44.9% | 48.9% | 47.1% | 46.3% | 45.1% | 49.8% |
| D&A ($bn) | 6.7 | 7.3 | 7.9 | 8.6 | 9.1 | 10.1 | 11.2 | 12.1 |
| EPS excl. OpenAI ($) | – | $3.46 | – | $4.13 | $4.14 | $4.27 | $4.74 | $4.89 |
| Capex incl. leases ($bn) | – | – | – | 34.9 | 37.5 | 31.9 | 41.0 | 45.2 |
| Commercial RPO ($bn) | 298 | 315 | 368 | 392 | 625 | 627 | 678 | 677 |
Source: Company filings and earnings calls, FQ2 FY25 to FQ1 FY27. Quarterly D&A is as reported in each 10-Q; annual D&A in Exhibit 57 is on the restated FY26 10-K basis. Capex shown from FQ1 FY26 only; EPS excludes OpenAI results and is shown where reported on that basis.
| Revenue by product, $bn | FY25A | FY26A | FY27E | FY28E | FY29E | FY29E y/y |
|---|---|---|---|---|---|---|
| Azure | 72.6 | 101.9 | 147.3 | 198.9 | 252.5 | +27.0% |
| Microsoft 365 cloud | 84.6 | 100.3 | 118.4 | 137.3 | 156.5 | +14.0% |
| Productivity and server licensing | 35.4 | 37.3 | 35.4 | 34.4 | 33.7 | -2.0% |
| Industry solutions | 18.4 | 20.3 | 22.0 | 23.7 | 25.4 | +7.0% |
| Frontier and support services | 7.8 | 8.3 | 8.6 | 8.8 | 9.1 | +3.0% |
| Search and advertising | 22.2 | 24.8 | 27.3 | 29.8 | 32.2 | +8.0% |
| XBOX | 23.5 | 21.8 | 22.0 | 22.7 | 23.3 | +3.0% |
| Windows OEM and devices | 17.3 | 17.1 | 14.0 | 14.3 | 14.4 | +1.0% |
| Total revenue | 281.7 | 331.8 | 395.0 | 469.8 | 547.2 | +16.5% |
Source: Form 8-K, 2 Sep 2026 (FY27 reporting structure, FY25A-FY26A restated); Penmark Research model (E, shaded).
Reference: every figure traces to the model, with a DCF primary method and a P/E cross-check that agree within 0.5%
| Topic | Note |
|---|---|
| Archetype | Recurring revenue: cloud consumption and subscriptions. Agents and Infra is 81% of FY26A revenue; Devices and Consumer, with Windows, Xbox and search, is 19% |
| Primary method | DCF to FY41, valued at 30 Sep 2026 and rolled to 6 Nov 2026; WACC 8.88%, terminal growth 3.0% at a 15% return on new capital |
| Cross-check | 22.55x platform-peer median on next-12-month EPS of $20.38, plus the OpenAI stake of $27.46 a share |
| Rejected methods | EV/FCF (FY27E FCF is near zero after finance-leased capex), EV/EBITDA (ignores capex), sum of the parts (segments share one fleet) |
| Rating rule | Model rule: return to value = weighted value ÷ price − 1; Buy above +10%, Sell below −10%; target = value × (1 + cost of equity − dividend yield). The disclosure page states the band on total return to target; both measures give Hold here (−5.2% and +3.5%) but can differ in sensitivities |
| Departures | Peer P/E bases differ slightly by provider; consensus data predate the FQ1 FY27 print |
Source: Penmark Research model (Methodology), data cut-off 8 Nov 2026; price date 6 Nov 2026. Fiscal year ends 30 June.
| Reconciliation | FY26A | FY27E |
|---|---|---|
| Operating income ($bn) | 155.2 | 183.6 |
| Other income, net, incl. OpenAI ($bn) | 10.7 | −1.6 |
| Net income ($bn) | 133.7 | 145.6 |
| Diluted EPS ($) | 17.95 | 19.55 |
| Diluted shares (m) | 7,453 | 7,446 |
| Effective tax rate | 19.4% | 20.0% |
| Consensus EPS, excl. OpenAI ($) | n/a | 20.02 |
Source: Company filings (A); Penmark Research model (E). Forecast net income excludes OpenAI investment gains and losses.
| Company | Group | P/E (NTM) | Op. margin |
|---|---|---|---|
| Alphabet | Platform | 17.9x | 31.8% |
| Amazon | Platform | 24.4x | 13.9% |
| Meta Platforms | Platform | 20.7x | 20.1% |
| Apple | Platform | 36.1x | 31.1% |
| Oracle | Infrastructure | 12.8x | 30.6%* |
| Salesforce | Applications | 14.2x | 20.5% |
| ServiceNow | Applications | 22.1x | 9.4% |
| Adobe | Applications | 9.2x | 36.6%* |
| Microsoft | Platform | 24.7x | 49.8% |
Source: Motley Fool, Zacks via Yahoo Finance (P/E, 2-6 Nov 2026); company filings, key metrics (latest quarter); Penmark Research. *Last full fiscal year from filings: Oracle FY26 (May 2026), Adobe FY25 (Nov 2025).
| Financials | Form 10-K FY26 (29 Jul 2026), Form 10-Q FQ1 FY27 (28 Oct 2026), Form 8-K (2 Sep 2026), earnings calls |
| Prices and index | Yahoo Finance closes to 6 Nov 2026; S&P 500 as index |
| Consensus and targets | Chartmill, 247 Wall St, TIKR, tickernerd, MarketBeat, Oct to 5 Nov 2026 |
| Ownership | SEC Form 13F (30 Jun 2026), FINRA short interest (15 Oct 2026), Form 4 insider filings (Oct 2026) |
| Cloud share and pay | Synergy Research Group (Q3 2026); Microsoft 2025 and 2026 proxy statements |
Source: As listed. Model data cut-off 8 Nov 2026.
Analyst certification and important disclosures
Ratings
Ratings reflect the expected total return to our 12-month price target, including dividends, weighted across bull, base and bear scenarios.
| Buy | Expected total return above +10% |
| Hold | Expected total return between −10% and +10% |
| Sell | Expected total return below −10% |
We review ratings at each set of results and whenever the facts change materially. A share price can move outside its band before the rating changes, and targets may not be reached.
Analyst certification
The Penmark Research Team certifies that (1) the views in this report accurately reflect its views about the subject company and its securities, and (2) no part of its compensation was, is or will be directly or indirectly related to the specific ratings, price targets or views in this report.
Contact
Penmark Research
Questions about our research:
research@penmarkresearch.com
All our research and coverage:
penmarkresearch.com
Basis of preparation
This report uses information publicly available up to its publication date. Share prices are closing prices on the trading day before the publication date, unless stated otherwise. Forecasts, valuations and price targets are Penmark Research’s own, and forecast periods are marked E. Sources are shown beneath each exhibit.
Valuation and price targets
Price targets are based on the valuation methods set out in each report and are weighted across bull, base and bear scenarios. The main risks to each rating and price target are described in the report. Penmark Research updates its coverage after each set of results but is not obliged to update a report at any other time.
Independence and conflicts of interest
Penmark Research is independent. It does not provide investment banking, brokerage, market-making or asset management services, does not trade securities, and does not accept payment from any company for research coverage. Companies do not see or review Penmark Research reports before publication.
No member of the Penmark Research Team holds a long or short position, directly or through derivatives, in the securities of any company Penmark Research covers.
Regulatory status
Penmark Research publishes general, impersonal investment research on a regular basis. It is not registered as an investment adviser with the US Securities and Exchange Commission or any state securities authority, is not a registered broker-dealer and is not a member of FINRA. Penmark Research does not give advice tailored to any person’s circumstances.
Not investment advice or an offer
This report is for information only. It is not personalised investment advice and is not an offer or solicitation to buy or sell any security or other financial instrument. It does not take into account any reader’s objectives, financial situation or needs. Readers should make their own investment decisions and seek independent professional advice where appropriate.
Forward-looking statements and risk
Forecasts, valuations and price targets are estimates based on assumptions that may prove wrong, and they may not be achieved. Opinions are current as of the publication date and may change without notice. Investing in equities involves risk, including the loss of capital. Share prices can be volatile, and past performance is not a reliable indicator of future results.
Data and sources
Company financials, operating data and filings come from company filings, earnings releases and earnings calls. Market data and any consensus estimates come from third-party sources named beneath the relevant exhibit; consensus figures from aggregators are unofficial. Penmark Research does not use other brokers’ research. Third-party data belong to their providers and may not be extracted from this report.
Accuracy and liability
Information is taken from sources believed to be reliable, but Penmark Research makes no representation or warranty as to its accuracy, completeness or timeliness. To the fullest extent permitted by law, Penmark Research accepts no liability for any loss arising from use of this report. Descriptions of litigation and regulatory matters reflect allegations and public records, not findings, unless stated. If a published report is corrected, the corrected version carries an “Updated” date at penmarkresearch.com.
Distribution and access
Penmark Research reports are available to registered users of penmarkresearch.com. Downloads and programmatic access are governed by the Penmark Research subscription terms. This report is not directed at, or intended for, any person in Singapore or India, and access from those countries is blocked. It is not intended for distribution to, or use by, any person in any jurisdiction where that would be contrary to law or regulation or would subject Penmark Research to registration or licensing requirements there.
Copyright and permitted use
© Penmark Research. All rights reserved. Penmark Research is a trade name of Brightriver Labs. Readers may share a link to this report but may not copy, reproduce, redistribute, sell or use its content, including for text and data mining, without written consent. Contact: research@penmarkresearch.com.